1-[4-(4-methylpiperazin-1-yl)phenyl]-3-[4-[4-[(1R,5S)-8-oxa-3-azabicyclo[3.2.1]octan-3-yl]-6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)pyrimidin-2-yl]phenyl]urea

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 1-[4-(4-methylpiperazin-1-yl)phenyl]-3-[4-[4-[(1R,5S)-8-oxa-3-azabicyclo[3.2.1]octan-3-yl]-6-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)pyrimidin-2-yl]phenyl]urea
• 化学式: C₃₄H₄₂N₈O₃
• 分子量: 610.7
• InChiKey: APIVDKUDTYSGEC-WNUBJLNHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.8
• 重原子数：
  45
• 可旋转键数：
  6
• 环数：
  8.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  98.3
• 氢给体数：
  2
• 氢受体数：
  9

文献信息

• INHIBITORS OF MTOR KINASE AS ANTI -VIRAL AGENT
  申请人：Shenk Thomas

  公开号：US20140206678A1

  公开（公告）日：2014-07-24

  The present invention provides methods for treating or preventing viral infections using modulators of host cell enzymes relating to mTOR. The invention also provides methods for treating or preventing viral infections using modulators of host cell enzymes relating to mTOR and modulators of the unfolded protein response.